Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer

Annals of Surgical Oncology

Volumn 16, Issue 11, 2009, Pages 3010-3019

  Fortunato, Lucio ^a   Mascaro, Alessandra ^a   Baldi, Alfonso ^b   Farina, Massimo ^a   Cortese, Giuliana ^c   Ventrone, Maria Antonietta ^b   Amini, Mostafà ^a   Vitelli, Carlo ^a  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER MORTALITY; CANCER RELAPSE; CANCER SIZE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE SEQUENCE; HOSPITAL PHYSICIAN; HUMAN; HUMAN TISSUE; ILIAC CREST; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN; YOUNG ADULT;

EID: 70350412281     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0619-x     Document Type: Article

References (43)

1. D Rosner WW Lane 1993 Predicting recurrence in axillary-node negative breast cancer patients Breast Cancer Res Treat. 25 127 9 10.1007/BF00662138 1:STN:280:DyaK3szltVaiuw%3D%3D 8347845
2. VT De Vita 1997 Breast cancer therapy: Exercising all our options N Eng J Med. 337 956 62 10.1056/NEJM199710023371402 (Pubitemid 27425951)
3. RA Ghossein S Bhattacharya J Rosai 1999 Molecular detection of micrometastatic and circulating tumor cells in solid tumors Clin Cancer Res. 5 1950 60 1:STN:280:DyaK1MvgtVSmsg%3D%3D 10473071
4. W Janni B Rack K Lindemann N Harbeck 2005 Detection of micrometastatic disease in bone marrow: is it ready for prime time? Oncologist. 10 480 92 10.1634/theoncologist.10-7-480 16079315 (Pubitemid 41266329)
5. Riethdorf S, Wilkman H, Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer. 2008;123:1991-2006.
6. S Braun FD Vogl B Naume W Janni MP Osborne RC Coombes, et al. 2005 A pooled analysis of bone marrow micrometastases in breast cancer N Engl J Med. 353 793 802 10.1056/NEJMoa050434 1:CAS:528:DC%2BD2MXovVKlu7s%3D 16120859 (Pubitemid 41215488)
7. M Gerhard H Juhl H Kalhoff H Schreiber C Wagener M Neumaier 1994 Specific detection of carcinoembryonic antigen expressing tumor cells in bone marrow aspirates by polymerase chain reaction J Clin Oncol. 12 725 9 1:STN:280:DyaK2c3gtFOrug%3D%3D 7512130
8. PJ Bostick DS Hoon RJ Cote 1998 Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer N Engl J Med. 339 1643 4 1:STN:280:DyaK1M%2Fjt1Snug%3D%3D 9867533
9. YS Jung KJ Lee HJ Kim, et al. 2003 Clinical significance of bone marrow micrometastasis detected by nested RT-PCR for keratin-19 in breast cancer patients Jpn J Clin Oncol. 33 167 72 10.1093/jjco/hyg038 12810830 (Pubitemid 43102859)
10. IH Benoy H Elst M Philips, et al. 2006 Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer Br J Cancer. 94 672 80 1:STN:280:DC%2BD287mtFegsA%3D%3D 16495933
11. RK Farmen O Nordgard B Gilje FV Shammas JT Kvaloy S Oltedal, et al. 2008 Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients Breast Cancer Res Treat. 108 251 8 10.1007/s10549-007-9592-x 1:CAS:528:DC%2BD1cXitleqsbc%3D 17492378 (Pubitemid 351311358)
12. M Ooka Y Tamaki I Sakita, et al. 2001 Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer Breast Cancer Res Treat. 67 169 75 10.1023/A:1010651632354 1:STN:280:DC%2BD3Mvns1ynsg%3D%3D 11519865 (Pubitemid 32744497)
13. Apostolaki S, Perraki M, Kallergi G, et al. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation on their prognostic relevance. Breat Cancer Res Treat. 2008; Nov 19 [Epub ahead of print].
14. L Fortunato M Amini L Costarelli FR Piro M Farina CE Vitelli 2007 A standardized sentinel lymph node enhanced pathology protocol (SEPP) in patients with breast cancer J Surg Oncol. 96 470 3 10.1002/jso.20767 1:STN:280: DC%2BD2snhtlCjug%3D%3D 17929258 (Pubitemid 350044389)
15. V Muller N Stahmann S Riethdorf, et al. 2005 Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity Clin Cancer Res. 11 3678 85 10.1158/1078-0432.CCR-04-2469 15897564 (Pubitemid 40685584)
16. JY Pierga C Bonneton A Vincent-Salomon, et al. 2004 Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients Clin Cancer Res. 10 1392 400 10.1158/1078-0432.CCR-0102-03 1:CAS:528:DC%2BD2cXhsVGjsLw%3D 14977842 (Pubitemid 38365234)
17. IH Benoy H Elst M Philips, et al. 2006 Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer Clin Breast Cancer. 7 146 52 10.3816/CBC.2006.n.024 1:CAS:528: DC%2BD28XntlyrsLg%3D 16800974
18. G Wiedswang E Borgen C Schirmer R Karesen G Kvalheim JM Nesland, et al. 2006 Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer Int J Cancer. 118 2013 9 10.1002/ijc.21576 1:CAS:528:DC%2BD28Xjt1GqurY%3D 16287086
19. M Ooka I Sakita Y Fujiwara, et al. 2000 Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients Oncol Rep. 7 561 6 1:CAS:528:DC%2BD3cXjtVOju70%3D 10767368
20. T Aihara Y Fujiwara M Ooka I Sakita Y Tamaki M Monden 1999 Mammaglobin B as novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction Breast Cancer Res Treat. 58 137 40 10.1023/A:1006335817889 1:CAS:528:DC%2BD3cXps1yjsA%3D%3D 10674878 (Pubitemid 30032485)
21. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996;56:860-5.
22. PN Span E Waanders P Manders, et al. 2004 Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time J Clin Oncol. 22 691 8 10.1200/JCO.2004.01.072 1:CAS:528:DC%2BD2cXpsVajsL8%3D 14966093 (Pubitemid 41095073)
23. A Marchetti F Buttitta G Bertacca, et al. 2001 mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients J Pathol. 195 186 90 10.1002/path.943 1:CAS:528:DC%2BD3MXns1ykurY%3D 11592097 (Pubitemid 32899027)
24. A Stathopoulou I Vlachonikolis D Mavroudis, et al. 2002 Molecular detection of cytokeratine-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance J Clin Oncol. 20 3404 12 10.1200/JCO.2002.08.135 1:CAS:528:DC%2BD38XntVyjsbg%3D 12177100 (Pubitemid 34894673)
25. MS Ismail W Wynendaele JL Aerts, et al. 2004 Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR Clin Cancer Res. 1 196 201 10.1158/1078-0432.CCR-0515-2 (Pubitemid 38114180)
26. S Becker G Becker-Pergola D Wallwiener EF Solomayer T Fehm 2006 Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy Breast Cancer Res Treat. 97 91 6 10.1007/s10549-005-9095-6 1:CAS:528:DC%2BD28Xks1Okur0%3D 16319975 (Pubitemid 43750952)
27. M Cristofanilli GT Budd MJ Ellis, et al. 2004 Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med. 351 781 91 10.1056/NEJMoa040766 1:CAS:528:DC%2BD2cXntVeitb4%3D 15317891 (Pubitemid 39095313)
28. FA Vlems TJM Ruers CJA Punt T Wobbes GNP van Muijen 2003 Relevance of disseminated tumor cells in blood and bone marrow of patients with solid epithelial tumours in perspective EJSO. 29 289 302 10.1053/ejso.2002.1394 1:STN:280:DC%2BD3s7pt1ejsQ%3D%3D 12711279 (Pubitemid 36675682)
29. KJ Luzzi IC MacDonald EE Schidt N Kerkvliet VL Morris AF Chambers, et al. 1998 Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases Am J Pathol. 153 865 73 1:STN:280:DyaK1cvgsFCnsA%3D%3D 9736035
30. K Pantel G Schlimok S Braun, et al. 1993 Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells J Nat Cancer Inst. 85 1419 24 10.1093/jnci/85.17.1419 1:STN:280: DyaK3szltlGntw%3D%3D 7688814
31. C Alix-Panabieres JP Vendrell O Pelle, et al. 2007 Detection and characterization of putative metastatic precursor cells in cancer patients Clin Chem. 53 537 9 10.1373/clinchem.2006.079509 1:CAS:528:DC%2BD2sXis1WnsLs%3D 17327507 (Pubitemid 46447957)
32. M Balic H Lin L Young D Hawes A Giuliano G McNamara, et al. 2006 Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype Clin Cancer Res. 12 5615 21 10.1158/1078-0432.CCR-06-0169 1:CAS:528:DC%2BD28XhtVartb3L 17020963 (Pubitemid 44629587)
33. V Bozionellou D Mavrouudis M Perraki, et al. 2004 Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer Clin Cancer Res. 10 8185 8194 10.1158/1078-0432.CCR- 03-0094 1:CAS:528:DC%2BD2cXhtFGjsrjP 15623593 (Pubitemid 40053377)
34. W Janni B Rack C Schindlbeck B Strobl D Rjosk S Braun, et al. 2005 The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence Cancer. 103 884 91 10.1002/cncr.20834 15666325 (Pubitemid 40270064)
35. G Wiedswang E Borgen R Karesen, et al. 2004 Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavourable clinical outcome Clin Cancer Res. 10 5342 8 10.1158/1078-0432.CCR-04-0245 15328170 (Pubitemid 39100469)
36. N Xenidis I Vlachonikolis D Mavroudis, et al. 2003 Peripheral blood circulating cytokeratin-19 mRNA-positive cells after completion of adjuvant chemotherapy in patients with operable breast cancer Ann Oncol. 14 849 55 10.1093/annonc/mdg259 1:STN:280:DC%2BD3s3mvFGnsQ%3D%3D 12796021 (Pubitemid 36827199)
37. S Braun CR Kentenich W Janni, et al. 2000 Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high risk breast cancer patients J Clin Oncol. 18 80 6 1:CAS:528: DC%2BD3cXmtFSrsQ%3D%3D 10623696
38. MJ Slade A Singh BM Smith, et al. 2005 Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years Int J Cancer. 114 94 100 10.1002/ijc.20655 1:CAS:528:DC%2BD2MXhtFCns7c%3D 15523696 (Pubitemid 40194313)
39. U Woelfle J Cloos G Sauter, et al. 2003 Molecular signature associated with bone marrow micrometastasis in human breast cancer Cancer Res. 63 5679 84 1:CAS:528:DC%2BD3sXnvVSjt7w%3D 14522883
40. EF Solomayer S Becker G Pergola-Becker 2006 Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients Breast Cancer Res Treat. 98 179 84 10.1007/s10549-005-9147-y 1:CAS:528:DC%2BD28XmvVarsro%3D 16552629 (Pubitemid 44050767)
41. P Wulfing J Borchard H Buerger S Heidl KS Zanker L Kiesel, et al. 2006 HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients Clin Cancer Res. 12 1715 20 10.1158/1078-0432.CCR- 05-2087 16551854
42. IH Benoy H Elst I Van der Auwera, et al. 2004 Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cell in bone marrow aspirates of patients with breast cancer Br J Cancer. 91 1813 20 10.1038/sj.bjc.6602189 1:CAS:528:DC%2BD2cXpsVOqur8%3D 15505629 (Pubitemid 39664970)
43. AE Ring L Zabaglo MG Ormerod IE Smith M Dowsett 2005 Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques Br J Cancer. 92 906 12 10.1038/sj.bjc.6602418 1:STN:280:DC%2BD2M7isVKitQ%3D%3D 15714202 (Pubitemid 40462638)